What Cardiff Oncology, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 4 |
| Sells | 0 | 0 |
| Total trades | 0 | 4 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 776,352 |
| Disposed | 0 | 0 |
| Net activity | +0 | +776,352 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mohindru Mani | Chief Executive Officer | Jul 14 | Open-market buy · P | +34,364 | $1.46 | +$50K | 59,067 |
| Pace Gary W | Director | Jul 14 | Open-market buy · P | +687,285 | $1.46 | +$1M | 2,043,661 |
| Pace Gary W | Director | Jun 18 | Open-market buy · P | +30,000 | $1.22 | +$36.6K | 1,356,376 |
| Mohindru Mani | Chief Executive Officer | Jun 18 | Open-market buy · P | +24,703 | $1.21 | +$29.9K | 24,703 |
| Pace Gary W | Director | Jul 30 | Open-market buy · P | +15,000 | $2.45 | +$36.8K | 1,345,676 |
| Pace Gary W | Director | Jul 30 | Open-market buy · P | +275,000 | $2.45 | +$674K | 1,330,676 |
| Levine James E. | Chief Financial Officer | Dec 18 | Open-market buy · P | +2,400 | $5.00 | +$12K | 67,716 |
| Levine James E. | Chief Financial Officer | Dec 17 | Open-market buy · P | +2,752 | $5.42 | +$14.9K | 65,316 |
| Levine James E. | Chief Financial Officer | Dec 16 | Open-market buy · P | +2,564 | $3.83 | +$9.82K | 62,564 |
| Tannenbaum Renee P | Director | Dec 12 | Open-market buy · P | +10,000 | $3.42 | +$34.2K | 20,000 |
| Pace Gary W | Director | Dec 11 | Open-market buy · P | +11,500 | $2.60 | +$29.9K | 1,059,376 |
| Pace Gary W | Director | Dec 11 | Open-market buy · P | +350,115 | $2.60 | +$910K | 1,047,876 |
| Pace Gary W | Director | Dec 19 | Open-market buy · P | +30,000 | $1.37 | +$41.1K | 697,761 |
| Pace Gary W | Director | Nov 10 | Open-market buy · P | +22,950 | $0.98 | +$22.5K | 667,761 |
| Erlander Mark | Chief Executive Officer | Nov 25 | Open-market buy · P | +10,000 | $1.43 | +$14.3K | 24,481 |
| White Lale | Director | Sep 19 | Open-market buy · P | +15,000 | $1.64 | +$24.5K | 113,788 |
| Levine James E. | Chief Financial Officer | Sep 16 | Open-market buy · P | +30,000 | $1.56 | +$46.7K | 60,000 |
| Armitage James O | Director | Sep 16 | Open-market buy · P | +13,000 | $1.56 | +$20.2K | 13,000 |
| Tannenbaum Renee P | Director | Sep 15 | Open-market buy · P | +3,600 | $1.72 | +$6.19K | 10,000 |
| Tannenbaum Renee P | Director | Sep 15 | Open-market buy · P | +6,400 | $1.72 | +$11K | 6,400 |
Loading...